BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cefdinir

A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.

298+ PubMed studies analyzed · 39 RCTs · Evidence Score: 48.3

Research Domains

Cefdinir has been studied across 13 research domains including 🫁 Respiratory, ✨ Skin & Hair, 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🫘 Kidney. The primary research focus is 🫁 Respiratory with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cefdinir, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cefixime
7 shared targets
Cefotetan
4 shared targets
Oxytetracycline
8 shared targets
Cefprozil
2 shared targets
Ceftibuten
2 shared targets
Cefazolin
3 shared targets
Cefpodoxime
2 shared targets
cefatrizine
2 shared targets
silver
2 shared targets
Cefmenoxime
2 shared targets
Loading evidence profile...

This evidence profile for Cefdinir is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.